New Perspectives in Managing HF and HK - The Cardiorenal Angle

New Perspectives in Managing HF and HK - The Cardiorenal Angle is organized by Medtelligence.

Released: 03/30/2022
Valid until: 03/30/2023

Description:
RAASi therapy is a critical component of heart failure management; however, concern about patients developing hyperkalemia often leads to clinical delay and suboptimal dosing. This is especially evident in our patients with chronic kidney disease. So how can we simultaneously maintain optimal therapy and manage hyperkalemia? Join Dr. Mikhail Kosiborod and Dr. Austin Stack as they discuss a patient case and make sure you’re staying up to date with the evolving data, guidelines, and practices.

Learning Objectives:
After participating in this educational activity, participants should be better able to:
• Discuss key considerations for the management of RAASi therapy in patients with heart failure (HF) and chronic kidney disease (CKD)
• Evaluate evidence-based approaches to the management of hyperkalemia in patients with HF and CKD
• Develop interdisciplinary strategies for the management of patients with HF and multiple comorbidities

Additional Details Will Be Posted as Soon as Information is Available.